Applied DNA Sciences, Inc. (NASDAQ:APDN) Q4 2022 Earnings Conference Call December 14, 2022 4:30 PM ET

Company Participants

Sanjay Hurry - Investor Relations

Beth Jantzen - Chief Financial Officer

James Hayward - Chairman, President and Chief Executive Officer

Conference Call Participants

Yi Chen - H.C. Wainwright & Co, LLC

Jason McCarthy - Maxim Group LLC

Operator

Good afternoon, and welcome to the Applied DNA Sciences Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions [Operator Instructions]. Please note this event is being recorded.

I would now like to turn the conference over to Sanjay Hurry, Investor Relations for Applied DNA. Please go ahead.

Sanjay Hurry

Thank you, Gary. Good afternoon, everyone, and welcome to Applied DNA's conference call to discuss our fourth quarter and fiscal year 2022 financial results. You can access the press release that was issued after market closed today, as well as the slide presentation accompanying this call on the Investor Relations section of our corporate website.

Speaking on the call today are Dr. James Hayward, our Chairman, President and CEO; and Beth Jantzen, our CFO. Judy Murrah, our COO; and Clay Shorrock, our Chief Legal Officer and Head of Business Development, will also be available to answer questions on the Q&A portion of the call.

Before we begin, please note that some of the information you will hear today during our discussion may consist of forward-looking statements. I refer you to Slide 2 of the presentation and to our Form 10-K filed a short while ago for important risk factors that could cause the company's actual performance and results to differ materially from those expressed or implied in any forward-looking statements. We undertake no obligation to update or revise any forward-looking statements or any other information provided on this call as a result of new information, future results or developments.

I also want to inform you that Jim and Clay will be in San Francisco next month at an offsite event to the annual JPMorgan Healthcare Conference, to meet with institutional investors and business development partners. If you'd like to meet with them, please contact me to schedule. You'll find my contact information at the bottom of today's earnings press release.

Now it's my pleasure to introduce our first speaker on today's call, Beth Jantzen. Please go ahead, Beth.